Parallax Volatility Advisers
RPRX

Parallax Volatility Advisers’s Repros Therapeutics Inc. RPRX Stock Holding History

Parallax Volatility Advisers’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-35,000
Closed -$260K – 4768
2015
Q3 		$260K Hold
35,000
– – ﹤0.01% 1739
2015
Q2 		$250K Buy
+35,000
New +$273K ﹤0.01% 1895

Other funds holding RPRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
AIA
Allegis Investment Advisors Idaho Falls, Idaho $326M AUM 10.36% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Parallax Volatility Advisers's RPRX Position: Q1 2016 in Review

Parallax Volatility Advisers sold out of Repros Therapeutics Inc. (RPRX) in Q1 2016, closing a stake of 1,559 shares — an estimated $2K sold.

Parallax Volatility Advisers first reported a position in RPRX in Q2 2015 and held it in 3 quarters. The position peaked at $100K in Q2 2015. 53 funds tracked by Wall St. Rank hold RPRX as of Q1 2016.

  • Parallax Volatility Advisers reported no remaining Repros Therapeutics Inc. position as of Q1 2016 after selling out during the quarter.
  • Parallax Volatility Advisers sold 1,559 Repros Therapeutics Inc. shares in Q1 2016, an estimated $2K.
  • Parallax Volatility Advisers first reported a position in Repros Therapeutics Inc. in Q2 2015 and held it in 3 quarters.
  • Parallax Volatility Advisers's Repros Therapeutics Inc. position peaked at $100K in Q2 2015.
  • 53 funds tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q1 2016.

Based on Parallax Volatility Advisers's 13F filing for Q1 2016, filed 16 May 2016.